These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 1937812)
1. Effects of gamma interferon, tumor necrosis factor alpha, and interleukin-2 on infection and proliferation of Theileria parva-infected bovine lymphoblasts and production of interferon by parasitized cells. DeMartini JC; Baldwin CL Infect Immun; 1991 Dec; 59(12):4540-6. PubMed ID: 1937812 [TBL] [Abstract][Full Text] [Related]
2. Differential in vitro and in vivo expression of MHC class II antigens in bovine lymphocytes infected by Theileria parva. DeMartini JC; MacHugh ND; Naessens J; Teale AJ Vet Immunol Immunopathol; 1993 Jan; 35(3-4):253-73. PubMed ID: 8430496 [TBL] [Abstract][Full Text] [Related]
3. Cytokines inhibit the development of trophozoite-infected cells of Theileria annulata and Theileria parva but enhance the proliferation of macroschizont-infected cell lines. Preston PM; Brown CG; Richardson W Parasite Immunol; 1992 Mar; 14(2):125-41. PubMed ID: 1570169 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide inhibits establishment of macroschizont-infected cell lines and is produced by macrophages of calves undergoing bovine tropical theileriosis or East Coast fever. Visser AE; Abraham A; Sakyi LJ; Brown CG; Preston PM Parasite Immunol; 1995 Feb; 17(2):91-102. PubMed ID: 7761113 [TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of Theileria parva is influenced by the host cell type infected by the parasite. Morrison WI; MacHugh ND; Lalor PA Infect Immun; 1996 Feb; 64(2):557-62. PubMed ID: 8550207 [TBL] [Abstract][Full Text] [Related]
6. Changes in the Molecular and Functional Phenotype of Bovine Monocytes during Bastos RG; Sears K; Dinkel KD; Knowles DP; Fry LM Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570561 [No Abstract] [Full Text] [Related]
7. Expression of Tac antigen component of bovine interleukin-2 receptor in different leukocyte populations infected with Theileria parva or Theileria annulata. Dobbelaere DA; Prospero TD; Roditi IJ; Kelke C; Baumann I; Eichhorn M; Williams RO; Ahmed JS; Baldwin CL; Clevers H Infect Immun; 1990 Dec; 58(12):3847-55. PubMed ID: 1979317 [TBL] [Abstract][Full Text] [Related]
8. Constitutive IL-2 mRNA expression in lymphocytes, infected with the intracellular parasite Theileria parva. Heussler VT; Eichhorn M; Reeves R; Magnuson NS; Williams RO; Dobbelaere DA J Immunol; 1992 Jul; 149(2):562-7. PubMed ID: 1624803 [TBL] [Abstract][Full Text] [Related]
9. Bovine gammadelta T-cell responses to the intracellular protozoan parasite Theileria parva. Daubenberger CA; Taracha EL; Gaidulis L; Davis WC; McKeever DJ Infect Immun; 1999 May; 67(5):2241-9. PubMed ID: 10225880 [TBL] [Abstract][Full Text] [Related]
10. Bovine cytotoxic T cell clones which recognize lymphoblasts infected with two antigenically different stocks of the protozoan parasite Theileria parva. Morrison WI; Goddeeris BM; Teale AJ Eur J Immunol; 1987 Dec; 17(12):1703-9. PubMed ID: 3121356 [TBL] [Abstract][Full Text] [Related]
11. Theileria parva: CD4+ helper and cytotoxic T-cell clones react with a schizont-derived antigen associated with the surface of Theileria parva-infected lymphocytes. Baldwin CL; Iams KP; Brown WC; Grab DJ Exp Parasitol; 1992 Aug; 75(1):19-30. PubMed ID: 1353459 [TBL] [Abstract][Full Text] [Related]
12. Bovine gamma/delta TcR+ T lymphocytes are stimulated to proliferate by autologous Theileria annulata-infected cells in the presence of interleukin-2. Collins RA; Sopp P; Gelder KI; Morrison WI; Howard CJ Scand J Immunol; 1996 Nov; 44(5):444-52. PubMed ID: 8947595 [TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated effector cells: modulation of activity by cytokines. Mehta S; Flanagan P; Blackinton D; Wanebo H Lymphokine Cytokine Res; 1992 Apr; 11(2):73-7. PubMed ID: 1581419 [TBL] [Abstract][Full Text] [Related]
14. IL-2 can enhance the cyclosporin A-mediated inhibition of Theileria parva-infected T cell proliferation. Eichhorn M; Magnuson NS; Reeves R; Williams RO; Dobbelaere DA J Immunol; 1990 Jan; 144(2):691-8. PubMed ID: 2104902 [TBL] [Abstract][Full Text] [Related]
15. Recognition of soluble Theileria parva antigen by bovine helper T cell clones: characterization and partial purification of the antigen. Brown WC; Lonsdale-Eccles JD; DeMartini JC; Grab DJ J Immunol; 1990 Jan; 144(1):271-7. PubMed ID: 2136883 [TBL] [Abstract][Full Text] [Related]
16. In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha. Brinchmann JE; Gaudernack G; Vartdal F J Acquir Immune Defic Syndr (1988); 1991; 4(5):480-8. PubMed ID: 1673156 [TBL] [Abstract][Full Text] [Related]
17. Theileria parva: reappearance of schizonts in infected lymphoblastoid cells treated with parvaquone is dependent on interleukin 2-like growth factors. Brown WC; Shaw MK; Conrad PA; Dolan TT Exp Parasitol; 1989 Apr; 68(3):308-25. PubMed ID: 2495228 [TBL] [Abstract][Full Text] [Related]
18. Production of interferon by Theileria annulata- and T. parva-infected bovine lymphoid cell lines. Ahmed JS; Wiegers P; Steuber S; Schein E; Williams RO; Dobbelaere D Parasitol Res; 1993; 79(3):178-82. PubMed ID: 8493239 [TBL] [Abstract][Full Text] [Related]
19. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of tumour necrosis factor-alpha and interferons by mononuclear cells from Theileria annulata-infected cattle. Preston PM; Brown CG; Entrican G; Richardson W; Boid R Parasite Immunol; 1993 Sep; 15(9):525-34. PubMed ID: 7533283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]